- 10,10'-Bis([1,1'-biphenyl]-4-yl)-9,9'-bianthracene
- 10,10'-Dibromo-9,9'-bianthryl
- 10,10-Dimethylanthrone
- 10,10-Oxybisphenoxarsine
- 10-[1,1'-Biphenyl]-4-yl-2-(1-methylethyl)-9-oxo-9H-thioxanthenium hexafluorophosphate
- 10,11-Dehydroimipramine
- 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine
- 10,11-Dihydro-2-(4-methyl-1-piperazinyl)-11-(2-athiazolyl)-pyridazino(3,4-b)(1,4)benzoxazepine
- 10,11-DIHYDRO-2-(4-METHYL-1-PIPERAZINYL)-11-(3,4-XYLYL)PYRIDAZINO(3,4b)(1,4)-BENZOXAZEPINE MALEATE
- 10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5h-dibenz (b,f)azepine
- 12015-10-0Californium oxide(CfO2) (7CI,9CI)
- 12015-14-4Ammonium chloride((ND4)Cl) (7CI,8CI,9CI)
- 120153-08-4Benzoic acid,4-borono-2-fluoro-
- 120157-60-01,3-Dioxolane-4-carboxaldehyde,2,2-diethyl-, (4R)-
- 120157-97-3Carbamic acid,N-[2-(4-bromophenyl)ethyl]-, 1,1-dimethylethyl ester
- 1201597-21-84-(2,6-difluoro-4-methylbenzoyl)-1H-pyrrole-2-carboxylic acid
- 120162-55-21H-Pyrazole-5-sulfonamide,N-[[(4,6-dimethoxy-2-pyrimidinyl)amino]carbonyl]-1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-
- 1201643-69-7[1,2,4]Triazolo[1,5-A]Pyridin-7-YlboronicAcid
- 1201643-71-1N-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methanesulfonamide
- 1201643-72-22-(4-(3-acetyl-8-bromo-3H-pyrazolo[3,4-c]quinolin-1-yl)phenyl)-2-methylpropanenitrile
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
1,2,3,4-Tetrahydro-6-methoxyquinoline |
EINECS | 204-374-8 |
| CAS No. | 120-15-0 | Density | 1.044 g/cm3 |
| PSA | 21.26000 | LogP | 2.19130 |
| Solubility | N/A | Melting Point |
37-41 °C(lit.) |
| Formula | C10H13 N O | Boiling Point | 303.4 °C at 760 mmHg |
| Molecular Weight | 163.219 | Flash Point | 116.5 °C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by intraperitoneal route. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | 36/37/38 |
| Molecular Structure |
|
Hazard Symbols |
 Xi
|
| Synonyms |
Thalline(6CI); 1,2,3,4-Tetrahydro-6-methoxyquinoline;6-Methoxy-1,2,3,4-tetrahydroquinoline; 6-Methoxytetrahydroquinoline; NSC 49188;Thallin |
Article Data | 107 |
1,2,3,4-Tetrahydro-6-methoxyquinoline Chemical Properties
IUPAC Name: 6-Methoxy-1,2,3,4-tetrahydroquinoline
The MF of 1,2,3,4-Tetrahydro-6-methoxyquinoline (CAS NO.120-15-0) is C10H13NO.
.gif)
The MW of 1,2,3,4-Tetrahydro-6-methoxyquinoline (CAS NO.120-15-0 is 163.22.
Synonyms of 1,2,3,4-Tetrahydro-6-methoxyquinoline (CAS NO.120-15-0: 6-Methoxytetrahydroquinoline ; Quinoline, 1,2,3,4-tetrahydro-6-methoxy-
Product Categories: Building Blocks;Heterocyclic Building Blocks;Quinolines
Index of Refraction: 1.532
EINECS: 204-374-8
Density: 1.044 g/ml
Flash Point: 116.5 °C
Boiling Point: 303.4 °C
Melting Point: 37-41 °C
1,2,3,4-Tetrahydro-6-methoxyquinoline Uses
1,2,3,4-Tetrahydro-6-methoxyquinoline (CAS NO.120-15-0 is used as chemical reagents, organic intermediates, fine chemicals, pharmaceutical research and development.
1,2,3,4-Tetrahydro-6-methoxyquinoline Toxicity Data With Reference
| 1. | ipr-mus LDLo:128 mg/kg | CBCCT* “Summary Tables of Biological Tests“ National Research Council Chemical-Biological Coordination Center. 2 (1950),62. |
1,2,3,4-Tetrahydro-6-methoxyquinoline Consensus Reports
Reported in EPA TSCA Inventory.
1,2,3,4-Tetrahydro-6-methoxyquinoline Safety Profile
Poison by intraperitoneal route. When heated to decomposition it emits toxic fumes of NOx.Safety information of 1,2,3,4-Tetrahydro-6-methoxyquinoline (CAS NO.120-15-0:
Hazard Codes 
Xi
Risk Statements
36/37/38 Irritating to eyes, respiratory system and skin
Safety Statements
26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36/37 Wear suitable protective clothing and gloves
WGK Germany 3
What can I do for you?
Get Best Price
